Imaging 11B-hydroxysteroid dehydrogenase availability in vivo

What is the purpose of this trial?

This study aims to assess the ability of the [F-18] MOZAT radiotracer to measure levels of 11β-HSD1 in the brain and the correlation of these levels with clinical and imaging biomarkers of PTSD. In order to accomplish this we will utilize both PET and MRI Imaging. 



Brain and Behavior Research Foundation

Start Date: 06/14/2017

End Date: 05/31/2020

Last Updated: 05/23/2018

Study HIC#: 2000020680

Get Involved

For more information about this study, contact:
Shannan Henry
+1 203-737-5278
shannan.henry@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image